These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2537566)

  • 1. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure.
    Stone CK; Uretsky BF; Linnemeier TJ; Shah PK; Amin DK; Snapinn SM; Rush JE; Langendörfer A; Liang CS
    Am J Cardiol; 1989 Mar; 63(9):567-70. PubMed ID: 2537566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
    Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lisinopril for severe congestive heart failure.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemaier T
    Am J Cardiol; 1989 Feb; 63(8):8D-11D. PubMed ID: 2537565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
    Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
    Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
    Woie L; Dickstein K; Kaada B
    Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.
    Bellissant E; Annane D; Pussard E; Thuillez C; Giudicelli JF
    Fundam Clin Pharmacol; 1996; 10(2):127-35. PubMed ID: 8737955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
    DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
    J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
    Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Cardiol; 1988 Nov; 62(13):912-6. PubMed ID: 2845768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
    Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
    Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
    Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON
    Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute haemodynamic effects of lisinopril and captopril in patients with severe congestive heart failure.
    Van Mieghem W; Van Hedent T; Byttebier G
    Acta Cardiol; 1993; 48(1):43-53. PubMed ID: 8383397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
    Hall D; Zeitler H; Rudolph W
    J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
    Cody RJ; Covit AB; Schaer GL; Laragh JH
    J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada.
    Parker AB; Azevedo ER; Baird MG; Smith SJ; Arnold JM; Humen DP; Moe GW; Parker JO; Butt RW; Parker JD
    Am Heart J; 1999 Nov; 138(5 Pt 1):843-8. PubMed ID: 10539814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.